Basic Information
Sandhill Therapeutics, founded in 2018, fully leverages the functions of natural killer (NK) cells and innate T-cell populations to maximize tumor killing and provide cost-effective universal cellular immunotherapy for cancer. At Sandhill, their mission is to offer patients the most powerful and cost-effective treatments for fighting cancer. The company’s universal dual-cell immunotherapy, BINATE™, is transforming cellular immuno-oncology.